This inventor holds 7 USPTO granted patents and 2 EPO patents. Top assignee: California Institute of Technology. Active years: 2009-2015.
Location History:
- Pasadena, CA (US) (2009 - 2013)
- Long Island City, NY (US) (2011 - 2015)
Company Filing History:
Years Active: 2009-2015
Title: Innovations of Robert Dirks
Introduction
Robert Dirks is a prominent inventor based in Pasadena, CA. He has made significant contributions to the field of molecular biology, particularly in the development of innovative techniques for RNA manipulation. With a total of 7 patents to his name, Dirks continues to push the boundaries of scientific research.
Latest Patents
One of Dirks' latest patents is focused on "PKR activation via hybridization chain reaction." This application relates to the use of hybridization chain reaction (HCR) to form double-stranded RNA polymers in the presence of a target, such as a nucleic acid associated with a disease or disorder. The RNA polymers are designed to activate the RNA-dependent kinase PKR, which can be utilized to treat a variety of diseases by specifically targeting diseased cells. Another notable patent is "Hybridization chain reaction amplification for in situ imaging." This invention employs fluorescently labeled nucleic acid probes to identify and image analytes in biological samples. The probe comprises a target region that binds specifically to an analyte of interest and an initiator region that initiates polymerization of nucleic acid monomers.
Career Highlights
Dirks is affiliated with the California Institute of Technology, where he conducts his research and development. His work has garnered attention for its potential applications in medical diagnostics and therapeutics.
Collaborations
Dirks has collaborated with notable scientists, including Niles A. Pierce and Scott E. Fraser, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Robert Dirks is a leading figure in the field of molecular biology, with a focus on innovative RNA technologies. His contributions through patents and collaborations continue to advance scientific understanding and potential therapeutic applications.